Mubadala Health has announced the successful complete acquisition of Union Pharmaceuticals and Global Medical Supply Chain from Global One Healthcare, which is part of the Yas Holding Group. This follows an initial acquisition of 80% at the end of 2024.
Strategic Significance of the Acquisition
This acquisition marks a key milestone in Mubadala Health’s journey to establish a comprehensive pharmaceutical manufacturing ecosystem in the UAE. The integration of pharmaceutical manufacturing processes and logistics under a unified strategy aims to bolster the growth and efficiency of the pharmaceutical sector.
Dr. Bakhit Al Khatiri, CEO of Investment at Mubadala, and Chairman of Mubadala Health, remarked, “This strategic move supports Mubadala Health’s integration efforts, enhancing operational efficiency and coordination across the pharmaceutical value chain. It also plays a crucial role in strengthening the national pharmaceutical security framework by ensuring the continuous availability of essential healthcare products nationwide.”
Commitment to Pharmaceutical Security
Lou Ping, CEO of Yas Holding Group, expressed, “We are pleased to confirm the full ownership transition and operational control of Union Pharmaceuticals and Global Medical Supply Chain to Mubadala Health. The capabilities and operational scope of both companies contribute to ensuring flexibility and efficiency, not only within Mubadala Health’s growing pharmaceutical ecosystem but also throughout the national healthcare supply chain.”
Through the complete acquisition of Union Pharmaceuticals and Global Medical Supply Chain, Mubadala Health reiterates its commitment to supporting the national pharmaceutical security system, enhancing vital pharmaceutical distribution networks, and creating an integrated pharmaceutical industry that aligns with the UAE’s ambitions to develop an innovative and sustainable healthcare sector.